1. 96. An open label study of synthetic psilocybin in bipolar type ii depression;Aaronson;Biol. Psychiatry,2023
2. Single-dose synthetic psilocybin with psychotherapy for treatment-resistant bipolar type ii major depressive episodes: a nonrandomized controlled trial;Aaronson;JAMA Psychiatry,2023
3. A case of prolonged mania, psychosis, and severe depression after psilocybin use: implications of increased psychedelic drug availability;Barber;Am. J. Psychiatry,2022
4. Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study;Bogenschutz;J. Psychopharmacol.,2015
5. Percentage of heavy drinking days following psilocybin-assisted psychotherapy vs placebo in the treatment of adult patients with alcohol use disorder: a randomized clinical trial;Bogenschutz;JAMA Psychiatry,2022